Home

About Me

Curriculum Vitae and Experience

PHA 525 Renal

PHA 411 Pharmacokinetics

Foundations of Pharmacy Practice

Wilkes Human Subjects Review

Personal

Discussion
Recent Discussion
Create New Topic

Membership

Login

Recent Publications

Book Chapters

1. Foote EF.  Syndrome of inappropriate antidiuretic hormone secretion and diabetes insipidus.  In: Tisdale JE, Miller DA, eds.  Drug-induced diseases: prevention, detection, and management.  Bethesthesda, ASHP;2005;611-624.
2. Elwell R.  Foote EF .  Hemodialysis and peritoneal dialysis.  In; Dipiro JT, Talbert RL, Yee GC, et al, eds.   Pharmacotherapy:  a pathophysiologic approach.   6^th ed. New York: McGraw-Hill; 2005:851-870

Articles in Peer-Reviewed Journals

1. Foote EF, Wood JA^*, Kinney JA.  A multidisciplinary, multifaceted approach to teaching empathy skills to first year pharmacy students.  In preparation.
2. Hollands JM^*, Foote EF.  Safety and efficacy of IV iron sucrose in hospitalized patients with CKD.  Accepted, American Journal of  Health-Systems Pharmacy.
3.  Foote EF, Germick D#.  Angiotensin Receptor Blockers in Dialysis Patients.  Submitted for publication to Seminars in Dialysis, September 2002.
4. Matzke GR, Comstock T, St. Peter WL, Foote EF. Nephrology Pharmaceutical Care Preceptorship: A Programmatic and Clinical Outcomes Assessment.  Annals of Pharmacotherapy 2000;34:593-9.
5. Constantinescu AR, Shah HB^#, Foote EF, Weiss LS.  Predicting first-year relapses in children with nephrotic syndrome.  Pediatrics 2000;105:492-495.
6. Dahl NV* , Foote EF, Kapoian T, Sherman RA.  Measuring total body water (TBW) in PD patients using an ethanol dilution technique.  Kidney International  1999;56:2297-2303
7.  Wong T^# , Foote EF, Lefavour GS, Cody RP, Brown CJ, Sherman RA.  Physician knowledge and practice patterns relating to diabetic nephropathy.  The Journal of the American Pharmaceutical Association  1999;39:785-790
8. Cournoyer S^#, Foote EF.  Use of fomepizole for ethylene glycol poisoning. Seminars in Dialysis.  1999;12:205-206.
9. Dahl NV*, Foote EF, Searson KM, Fein JL, Kapoian T, Steward CA, Sherman RA.  Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.  Annals of Pharmacotherapy.  1998;12:1284-1289
10. Foote EF, Dreitlein WB^# , Kapoian T, Steward CA, Walker JA, Sherman RA.  Pharmacokinetics  of vancomycin when administered during high flux hemodialysis. Clinical Nephrology 1998;50:51-55 July
11. Spinler SA, Nawarskas JJ, Foote EF, Sabapathi D, Connors JE, and Marchlinski FE. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center. Clinical Infectious Diseases 1998;26:1111-1116 May
12. Foote EF, Dahl NV*.  More drug idiosyncrasies in end-stage renal disease. Seminars in Dialysis 1998;11:167-174  May-June
13. Foote EF, Halstenson CE. Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats. Antimicrobial Agents and Chemotherapy 1998;42:456-458.

 Published Abstracts

1. Kotsko JA#, Foote EF, Ritter JL, Roke-Thomas M, Kulp B, Young SM, Rothschild JA.  Effect of Oxandrolone in dialysis patients. Pharmacotherapy, 2005.
2. TPA for Central Venous Dialysis Catheter Patency.  O¢â¡ÁMara NB, Ali SA, Foote EF, Bivens KA, Steward CA, Sherman RA, Kapoian T. Journal of the American Society of Nephrology.  2000;11:292A.
3. Melendez M.*, Calvanelli BL, Foote EF, Dahl NV, Sherman RA, Kapoian T.  Pharmacokinetics of intermittent cefazolin during continuous cycling peritoneal dialysis.  Journal of the American Society of Nephrology.  2000;11:213A.
4.  Rizkala AR*, Foote EF,  Protopapadakis P, Roberts R, Fenton T, Dahl N, Kapoian T.  Impact of a pharmacy/nursing driven anemia management program on hemodialysis patients of a hospital-based dialysis unit.  Pharmacotherapy  2000;20:366
5. Drabik TE*, Foote EF, Melendez OM, Dahl NV, Steward CA, Miholics B, Sherman RA, Walker JA, Kapoian T.  Pharmacokinetics of cefazolin during high-flux hemodialysis in patients with residual renal function.  Journal of the American Society of Nephrology  1999;10:190A
6. Matzke GR, St. Peter WL, Comstock TJ, Foote EF.  Nephrology pharmaceutical care preceptorship:  A programmatic and clinical outcomes assessment.  Pharmacotherapy  1999;19:540-541.
7. Foote EF, Melendez O*, Heyman ML* , Dahl NV. Documentation of pharmaceutical care activities in an outpatient hemodialysis (HD) unit.  Pharmacotherapy  1999;19:518.

Comment On This Page